MindMate is a dementia app developed by graduates of the University of Glasgow and Strathclyde University and includes games, workouts, recipes, vintage TV and music and problem-solving activities to stimulate cognitive abilities and keep users active. The company raised the funding from Connecticut-based LaunchCapital, San Francisco-based Telegraph Hill Capital, Mucker Capital and Luma Launch in Santa Monica, Los Angeles-based PLG Ventures, and London-based Potential VC. Users – predominantly Alzheimer’s sufferers – can access information about the latest...
Chromosomal loop signatures found in blood samples obtained in early rheumatoid arthritis could identify patients that will not respond adequately to ‘anchor’ treatment drug methotrexate. New University of Glasgow research, published in the Journal of Translational Medicine, investigated whether differences in genomic architecture, as defined by a chromosome conformation signature (CCS) in blood taken pre-treatment from people with early rheumatoid arthritis, could assist in identifying the...
The new approach reduces pain levels compared with conventional care, the research with patients shows. Researchers at the University of Edinburgh worked with doctors to develop the Edinburgh Pain Assessment and management Tool (EPAT) – a pen and paper chart which medical staff use to regularly record pain levels in a simple traffic light system. Using a traffic light system – amber or red pain levels...
Researchers at the Institute of Health and Wellbeing have been awarded £1m to enhance mental health data cohorts through linkage to health, education and administrative datasets. The UK-wide grants total £10m and are awarded by the Medical Research Council (MRC) to help researchers harness the power of data science for mental health research. Scotland is world-leading in the use of routine health data and record...
MIME Technologies, a University of Aberdeen medical technology spin-out developing software to monitor the vital signs of patients when emergency care situations arise in remote locations, is targeting the short-haul aviation sector with its first product. Designed specifically for environments where there is no immediate access to professional medical care, ‘MIME Pro’ has been developed to operate on-scene with or without connectivity. Now headquartered in Inverness,...
Private equity group Platinum Equity has offered Johnson & Johnson $2.1 billion for LifeScan. J&J has until the middle of June to accept the offer for its blood glucose monitoring business. J&J signaled its interest in offloading LifeScan and two other diabetes device units—Animas and Calibra Medical—at the start of last year. Since then, Chinese investors have reportedly weighed up bids for the units. But Los...